Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events

Medicilon Events

Hot information:
Two Innovative Service Platforms of Medicilon were Selected as Shanghai International Service Trade Demonstration project| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Sep 05,2020
Online Seminar for Identification and validation of novel therapeutic targets in both breast and kidney cancers
Please reserve for your seat at the below eventbrite link for free. https://www.eventbrite.com/e/novel-therapeutic-targets-in-both-breast-and-kidney-cancers-tickets-119195604261 Hypoxia is associated with resistance towards radiation and chemotherapy. As tumors grow,
More
Online Seminar for Identification and validation of novel therapeutic targets in both breast and kidney cancers
Aug 20,2020
A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC (Stock Code: 688202. SH) and Yichang Humanwell
More
A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Aug 13,2020
Medicilon will participate in ACS Fall 2020 Virtual Meeting & Expo
Medicilon will exhibit the ACS Fall 2020 Virtual Meeting & Expo from Aug 17-20.  Please visit https://calendly.com/fywang to schedule a 1-on-1 meeting with our VP
More
Medicilon will participate in ACS Fall 2020 Virtual Meeting & Expo
Aug 13,2020
Application of Solid Dispersion Technology in Formulation Development
On July 20, 2020, DAC Biotech's new ADC drug development, TROP2-ADC—DAC-002 was approved of clinical study by NMPA. for the indication of solid malignant tumor.
More
Application of Solid Dispersion Technology in Formulation Development
Jun 30,2020
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies. Based on previous cooperation
More
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Jun 15,2020
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Due to the COVID-19 pandemic, the 2020 SAPA Healthcare Investment Forum & Roadshow will be divided in 2 parts.  Part I will be hosted as
More
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Jun 04,2020
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Congratualtions to Medicilon's partner, Bio-Thera, on obtaining NMPA's approval of clinical trials of BAT1308. On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of
More
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Jun 01,2020
Medicilon received the "Most Improved in the Science and Technology” award
Good News! Led by Dr. CHUN-LIN CHEN, the founder and CEO of Shanghai Medicilon Inc., the entreprenuer team in Medicilon received the "Most Improved in
More
Medicilon received the "Most Improved in the Science and Technology” award
May 29,2020
The Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research
On May 21st 2020, the Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research. Dr. Chunlin Chen, Founder
More
The Deputy Mayor of Haining Municipal Government Yang Wenhua and his team visited Medicilon for the research
Apr 22,2020
Medicilon Preclinical Research-Mouse Tumor Model
As the incidence and mortality of cancer have increased year by year, cancer has become the primary enemy threatening human health. Therefore, more and more
More
Medicilon Preclinical Research-Mouse Tumor Model
Apr 21,2020
Formulation Research of Innovative Drugs
Zhangjiang Runhe International Office Garden Opened On April 15, 2020, the opening ceremony of Zhangjiang Runhe International Office Garden was successfully held.  The Member of
More
Formulation Research of Innovative Drugs
Apr 17,2020
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises
Malignant tumors, Alzheimer's disease, diabetes, rheumatoid arthritis… These intractable diseases that threaten human health have long plagued us, bringing pain and suffering to unfortunate patients,
More
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises